Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Depomed Inc (DEPO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart

Fundamentals

See More
  • Market Capitalization, $K 635,868
  • Shares Outstanding, K 62,340
  • Annual Sales, $ 455,900 K
  • Annual Income, $ -88,720 K
  • 36-Month Beta 1.32
  • Price/Sales 1.42
  • Price/Cash Flow 16.70
  • Price/Book 2.81

Price Performance

See More
Period Period Low Period High Performance
1-Month
9.50 +7.37%
on 05/10/17
12.35 -17.41%
on 04/27/17
-2.13 (-17.27%)
since 04/26/17
3-Month
9.50 +7.37%
on 05/10/17
16.65 -38.74%
on 03/01/17
-6.12 (-37.50%)
since 02/24/17
52-Week
9.50 +7.37%
on 05/10/17
27.02 -62.25%
on 09/30/16
-9.81 (-49.03%)
since 05/26/16

Most Recent Stories

More News
Depomed Rises 4.65% on Heavy Volume: Watch For Potential Pullback

Depomed (NASDAQ:DEPO) traded in a range yesterday that spanned from a low of $10.01 to a high of $10.64. Yesterday, the shares gained 4.7%, which took the trading range above the 3-day high of $10.45...

DEPO : 10.20 (-1.83%)
Depomed Announces Corporate Governance Updates

Depomed, Inc. (Nasdaq:DEPO) today announced that following a comprehensive review of the Company's corporate governance practices, the Board of Directors has taken a number of actions designed to ensure...

DEPO : 10.20 (-1.83%)
Depomed Shares Down 54.7% Since SmarTrend's Sell Call (DEPO)

SmarTrend identified a Downtrend for Depomed (NASDAQ:DEPO) on October 28th, 2016 at $22.73. In approximately 7 months, Depomed has returned 54.73% as of today's recent price of $10.29.

DEPO : 10.20 (-1.83%)
Depomed to Present at the UBS Global Healthcare Conference

Depomed, Inc. (NASDAQ:DEPO) today announced that members of senior management will participate in a fireside chat at the 2017 UBS Global Healthcare Conference scheduled for 10:00 am ET (7:00 am PT) on...

DEPO : 10.20 (-1.83%)
Today's Research Reports on Stocks to Watch: Rexahn Pharmaceuticals and Depomed

NEW YORK, NY / ACCESSWIRE / May 12, 2017 / Disappointing earnings from the consumer discretionary sector pressured markets lower Thursday. The Dow Jones Industrial Average hit an intraday low of 20,798.90...

RNN : 4.04 (+2.28%)
KSS : 38.73 (-0.36%)
DEPO : 10.20 (-1.83%)
Depomed Down 48.8% Since SmarTrend Downtrend Call (DEPO)

SmarTrend identified a Downtrend for Depomed (NASDAQ:DEPO) on October 28th, 2016 at $22.73. In approximately 7 months, Depomed has returned 48.83% as of today's recent price of $11.63.

DEPO : 10.20 (-1.83%)
Depomed Announces First Quarter 2017 Financial Results and Strategic Initiatives Aimed at Driving Sustainable Long-Term Growth and Shareholder Value

- First Quarter GAAP Revenues of $90 million, non-GAAP Revenues of $95 million -

DEPO : 10.20 (-1.83%)
Investor Network: Depomed, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / May 9, 2017 / Depomed, Inc. (NASDAQ: DEPO) will be discussing their earnings results in their Q1 Earnings Call to be held May 9, 2017 at 4:30 PM Eastern Time.

DEPO : 10.20 (-1.83%)
Depomed to Report First Quarter 2017 Financial Results on Tuesday, May 9, 2017

Depomed, Inc. (NASDAQ:DEPO) today announced that it will release first quarter fiscal year 2017 financial results on Tuesday, May 9, 2017, after the close of markets. The Company will host a conference...

DEPO : 10.20 (-1.83%)
Shares of DEPO Down 45.6% Since Downtrend Call on Shares

SmarTrend identified a Downtrend for Depomed (NASDAQ:DEPO) on October 28th, 2016 at $22.73. In approximately 6 months, Depomed has returned 45.62% as of today's recent price of $12.36.

DEPO : 10.20 (-1.83%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

See More

Business Summary

Depomed, Inc. is a specialty pharmaceutical company utilizing its innovative AcuForm drug delivery technology to develop novel oral products and improved, extended release formulations of existing oral drugs. AcuForm-based products are designed to provide once- daily administration and reduced side effects,...

See More

Support & Resistance

2nd Resistance Point 10.89
1st Resistance Point 10.54
Last Price 10.20
1st Support Level 9.93
2nd Support Level 9.67

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.